Bibliografia

  • Aires CC, Ijlst L, Stet F, Prip-Buus C, de Almeida IT, Duran M, Wanders RJ, Silva MF. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem Pharmacol. 2010 Mar 1;79(5):792-9. doi: 10.1016/j.bcp.2009.10.011. Epub 2009 Oct 23.
  • Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA, Sayed-Ahmed MM. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev. 2010 Nov-Dec;3(6):428-33. Epub 2010 Nov 1.
  • Arduini A1, Denisova N, Virmani A, Avrova N, Federici G, Arrigoni-Martelli E. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and pospholipid fatty acid turnover. J Neurochem. 1994 Apr;62(4):1530-8.
  • Arenas J, Rubio JC, Martín MA, Campos Y. Biological roles of L-carnitine in perinatal metabolism. Early Hum Dev. 1998 Dec;53 Suppl:S43-50.
  • Bach AC, Schirardin H, Sihr MO, Storck D. Free and total carnitine in human serum after oral ingestion of L-carnitine. Diabete Metab. 1983 May-Jun;9(2):121-4.
  • Bazzato G, Coli U, Landini S, Mezzina C, Ciman M. Myasthenia-like syndrome after D,L- but not L-carnitine. Lancet. 1981 May 30;1(8231):1209.
  • Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2001 Aug;86(8):3579-94.
  • Bernardini I, Rizzo WB, Dalakas M, Bernar J, Gahl WA. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest. 1985 Apr;75(4):1124-30.
  • Bieber LL, Emaus R, Valkner K, Farrell S. Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed Proc. 1982 Oct;41(12):2858-62.
  • Biochimica: di Berg Jeremy M.; Tymoczko John L.; Stryer Lubert ; Zanichelli
  • Bohan TP, Helton E, McDonald I, König S, Gazitt S, Sugimoto T, Scheffner D, Cusmano L, Li S, Koch G. Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology. 2001 May 22;56(10):1405-9.
  • Brass EP. Carnitine and sports medicine: use or abuse? Ann N Y Acad Sci. 2004 Nov;1033:67-78.
  • Brass EP. Supplemental carnitine and exercise. Am J Clin Nutr. 2000 Aug;72(2 Suppl):618S-23S.
  • Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, Attisano T, Ambrosio G, Siliprandi N, Angelini C. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation. 1988 Apr;77(4):767-73.
  • Brieger K, Schiavone S, Miller FJ Jr, Krause KH. Reactive oxygen species: from health to disease. Swiss Med Wkly. 2012 Aug 17;142:w13659. doi: 10.4414/smw.2012.13659. Review.
  • Briones TL, Woods Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. J. BMC Neurosci. 2011 Dec 9;12:124. doi: 10.1186/1471-2202-12-124.
  • Chapoy PR, Angelini C, Brown WJ, Stiff JE, Shug AL, Cederbaum SD. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med. 1980 Dec 11;303(24):1389-94.
  • Chen SD, Chang AY, Chuang YC. The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis. J Bioenerg Biomembr. 2010 Dec;42(6):461-5. doi: 10.1007/s10863-010-9321-8. Review.
  • Cherchi A, Lai C, Angelino F, Trucco G, Caponnetto S, Mereto PE, Rosolen G, Manzoli U, Schiavoni G, Reale A, et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol. 1985 Oct;23(10):569-72.
  • Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A. Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol. 2012 Oct;23(10):2547-52. Epub 2012 Mar 6.
  • Cifone MG, Alesse E, Di Marzio L, Ruggeri B, Zazzeroni F, Moretti S, Famularo G, Steinberg SM, Vullo E, De Simone C. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients. Proc Assoc Am Physicians. 1997 Mar;109(2):146-53.
  • De Simone C, Tzantzoglou S, Famularo G, Moretti S, Paoletti F, Vullo V, Delia S. High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. Immunopharmacol Immunotoxicol. 1993 Jan;15(1):1-12.
  • Du J, Cullen JJ, Buettner GR. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 2012 Dec;1826(2):443-57. doi: 10.1016/j.bbcan.2012.06.003. Epub 2012 Jun 20. Review.
  • Dutta Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. V. J Cancer Res Ther. 2011 Jul-Sep;7(3):264-9. doi: 10.4103/0973-1482.87008. Review.
  • Dutta V. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. J Cancer RES Ther 2011 Jul-Sep;7(3):264-9. doi: 10.4103/0973-1482.87008.
  • Engel AG, Rebouche CJ. Carnitine metabolism and inborn errors. J Inherit Metab Dis. 1984;7 Suppl 1:38-43.
  • Fatouros IG, Douroudos I, Panagoutsos S, Pasadakis P, Nikolaidis MG, Chatzinikolaou A, Sovatzidis A, Michailidis Y, Jamurtas AZ, Mandalidis D, Taxildaris K, Vargemezis V. Effects of L-carnitine on oxidative stress responses in patients with renal disease. Med Sci Sports Exerc. 2010 Oct;42(10):1809-18. doi: 10.1249/MSS.0b013e3181dbacab.
  • Fernandez C. et al., JAMA (Ed. It.), 1985, 9, 2.
  • Fondamenti di biochimica: V. Donald; Voet Judith G.; Pratt Charlotte W.; Zanichelli
  • Frassetto L. and Sebastan A. - "Age and Systemic Acid-Base Equilibrium", Analysis of Pubblished Data, Journal of Genrontology: Biological Sciences 1996, Vol51A. N° 1,B91-B99
  • Frassetto L. et al - "Diet, evolution and aging", European Journal of Nutrition, Vol40, N° 5, 2001
  • Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):243-51.
  • Galassetti P. Inflammation and oxidative stress in obesity, metabolic syndrome and diabetes. Exp Diabetes Res. 2012;2012:943706
  • Georgala S, Schulpis KH, Georgala C, Michas T. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy. J Eur Acad Dermatol Venereol. 1999 Nov;13(3):205-9.
  • Goa KL, Brogden RN. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs. 1987 Jul;34(1):1-24.
  • Grzybowska-Szatkowska L, Slaska B. Mitochondrial DNA and carcinogenesis (review). Mol Med Rep. 2012 Nov;6(5):923-30. doi: 10.3892/mmr.2012.1027. Epub 2012 Aug 9. Review.
  • Guarnieri G. et al., Kidney Int., 1987, 32 (Suppl. 22), S116.
  • Hamilton J.W. et al., Gastroenterol., 1986, 91, 10.
  • Harper P, Elwin CE, Cederblad G. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol. 1988;35(5):555-62.
  • Herink J. Enhancing effect of L-carnitine on some abnormal signs induced by pentylenetetrazol. Acta Medica (Hradec Kralove). 1996;39(2):63-6.
  • Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med. 2001 Jun 1;110(8):616-22.
  • Holme E. et al., Lancet, 1989, ii, 469.
  • Hug G, McGraw CA, Bates SR, Landrigan EA. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children. J Pediatr. 1991 Nov;119(5):799-802.
  • Hulsmann WC, Peschechera A, Serafini F, Ferrari LE. Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: role of endogenous long-chain acylcarnitine. Mol Cell Biochem. 1996 Mar 9;156(1):87-91.
  • Hurria A, Somlo G, Ahles T. Renaming "chemobrain". Cancer Invest. 2007 Sep;25(6):373-7. Review.
  • Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, Biasco G, Hugenholtz PG, Rizzon P. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995 Aug;26(2):380-7.
  • Janiri L, Tempesta E. Int J Clin Pharmacol Res. 1983;3(4):295-306. A pharmacological profile of the effects of carnitine and acetyl carnitine on the central nervous system.
  • Johnston C.S. et al., J. Am. Coll. Nutr., 1996, 15 (6), 586.
  • Karpati G. et al., Neurology, 1975, 25, 16.
  • Kawasaki N. et al., J. Card. Fail., 1996, 2, 293.
  • Keith R.E., JAMA, 1986, 255, 1137.
  • Kuntzer T. et al., J. Neurol., 1990, 237 (8), 495.
  • Kurz C. et al., Z. Geburtshilfe Perinatol., 1993, 197 (5), 215.1993
  • Lancet, 1990, 17, 631.
  • Laub M.C. et al., Epilepsia, 1986, 27, 559.
  • Leah M. Pyter; Brian J. Prendergast. Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen. Psyconeuroendocrinoloy 2012
  • Lenzi A. et al., Fertil. Steril., 2003, 79, 292.
  • Liedtke A.J. et al., Circ. Res., 1978, 43, 652.
  • Lissoni P. et al., Tumori, 1993, 79 (3), 202.
  • Liu J. et al., Ann. NY Acad. Sci., 2004, 1033, 117.
  • Liu J. et al., Proc. Natl. Acad. Sci. USA, 2002, 99, 1876.
  • Liu J. et al., Proc. Natl. Acad. Sci. USA, 2002a, 99, 2356.
  • Lohninger A. et al., J. Perinat. Med., 1996, 24, 591.
  • Malaguarnera M. et al., Arch. Gerontol. Geriatr., 2008, 46 (2), 181.
  • Matsuda I. et al., J. Pediatr., 1986, 109, 131.
  • Melegh B. et al., Eur. J. Pediatr., 1997, 156 (10), 795.
  • Mingrone G., Ann. NY Acad. Sci., 2004, 1033, 99.
  • Monje M, Dietrich Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. J. Behav Brain Res. 2012 Feb 14;227(2):376-9. doi: 10.1016/j.bbr.2011.05.012. Epub 2011 May 23. Review.
  • Monje M. Cranial radiation therapy and damage to hippocampal neurogenesis. Dev Disabil Res Rev. 2008;14(3):238-42. doi: 10.1002/ddrr.26. Review.
  • Montgomery S.A. et al., Int. Clin. Psychopharmacol., 2003, 18, 61.
  • Moretti S. et al., Antioxid. Redox Signal, 2002, 4, 391.
  • Moretti S. et al., Blood, 1998, 91, 3817.
  • Nanni G. et al., Am. J. Clin. Nutr., 1983, 38 (2), 339.
  • Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care. 2007 Sep;5(3):273-80. Review.
  • Neri S. et al., Neuropsychobiology, 2003, 47 (2), 94.
  • O’Donnell J. et al., Pediatrics, 2002, 109, 622.
  • Okin D, Medzhitov R. Evolution of inflammatory diseases Curr Biol. 2012 Sep 11;22(17):R733-40.
  • Palmero S. et al., Horm. Metab. Res., 2000, 32, 87.
  • Platell C. et al., J. Gastroenterol. Hepatol., 2000, 15, 706.
  • Prakova Gospodinga R. - "Mornitoring of Acid-Base Status of Workers at a methylMethacrylate and Polymethyl Metha crylate Production Plant in Bulgaira", American Industrial Hygiene Association Journal 64:11-16, 2003
  • Principi di biochimica: di Nelson David L.; Cox Michael M. ; Zanichelli
  • Rebouche C.J. et al., Biochem., 1984, 23, 642.
  • Rebouche C.J., Ann. NY Acad. Sci., 2004, 1033, 30.
  • Rebouche C.J., Chenard C.A., J. Nutr., 1991, 121 (4), 539.
  • Rebouche C.J., Engel A.G., J. Clin. Invest., 1984, 73, 857.
  • Rebouche C.J., Modern Nutrition in Health and Disease, 9th Edition, Lippincott Williams and Wilkins, New York, 1999, pp. 505.
  • Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Fee Radic Biol Med. 2011 Jul 15;51(2):327-36.
  • Rizzon P. et al., Eur. Heart J., 1989, 10, 502.
  • Romero-Falcon A. et al., Eur. J. Intern. Med., 2003, 14 (5), 338.
  • Sahajwalla C.G. et al., J. Pharm. Sci., 1995, 84, 627.
  • Schmidt-Sommerfeld E. et al., Contracept. Gyn. Obst., 1985, 13, 141.
  • Sekas G., Paul H.S., Am. J. Med., 1993, 95 (1), 112.
  • Semino-Mora M.C. et al., Lab. Invest., 1994, 71 (1), 102.
  • Sigman M. et al., Fertil. Steril., 2006, 85 (5), 1409.
  • Singh R.B. et al., Postgrad. Med. J., 1996, 72, 45.
  • Spagnoli L.G., Lancet, 1982, 1, 1419.
  • Taillia H. What's new concerning the chemobrain?. Rev Neurol (Paris). 2013 Mar;169(3):216-22. doi: 10.1016/j.neurol.2012.06.020. Epub 2012 Oct 26.
  • Torrioli M.G. et al., Am. J. Med. Genet. A., 2008, 146 (7), 803.
  • Triggs W.J., J. Neurol. Neurosurg. psychiatry, 1992, 55 (3), 209.
  • Van Hinsberg V.W. et al., Biochem. Med., 1978, 20, 115.
  • Van Hinsberg V.W. et al., Int. J. Biochem., 1980, 12, 559.
  • Vicari E. et al., Hum. Reprod., 2001, 16, 2338.
  • Virmani A. et al., Ann. NY Acad. Sci., 2003, 993, 197.
  • Vitali G. et al., Drugs Exp. Clin. Res., 1995, 21, 157.
  • Waber L.J. et al., J. Pediatr., 1982, 101, 700.
  • Wall B.T. et al., J. Physiol., 2011, 589 (Pt 4), 963.
  • Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012 Oct;12(10):685-98.Review.
  • Wang Sang - "Reverse Aging", ISP Publishing, Miami FL, 1990 
  • Weschler A. et al., Nephron., 1984, 38, 120.
  • Whitfield J. et al., Pediatrics, 2003, 111, 477.
  • Winter B.K. et al., Br. J. Cancer, 1995, 72 (5), 1173.
  • Wyss V. et al., Eur. J. Appl. Physiol. Occup. Physiol., 1990, 60 (1), 1.
© tutti i diritti riservati - disclaimer - seguici su facebook
Software by Olga de Aloe